Browse Contents
Select Volume:  

Select Issue:  

Select Article:

Abstracted/Indexed in


"The new journal on Recent Patents on Anti-Cancer Drug Discovery is an important patent journal in the field of Anti-Cancer Drug Discovery, which should provide research scientists in the field with recent developments in various frontier areas. The journal is strongly recommended to the scientific community."

Robert Huber
Nobel Laureate

Forthcoming Special Issues

Metabolic Targeting of Cancers

Guest Editor(s): Hongbin Sun, Huaming Sheng
Tentative Publication Date: January, 2016
Submit Abstract via Email Download Description
Authors' Comments
Thank you for your email. We are pleased to be the part of bentham science publishers through this esteemed journal. We wish to thank the editorial team and the reviewers for their excellent efforts in the improvement of our manuscript. It will be our great pleasure to recommend the journal to other researchers working in this area.

Arunaksharan Narayanankutty
(Department of Biochemistry, Amala Cancer Research Centre, Thrissur, Kerala, India)

Recent Patents on Anti-Cancer Drug Discovery


Volume 13


Number 1


Review Article

Review Article

Review Article

Review Article

Review Article

Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 13(1): 86 - 105

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*

DOI: 10.2174/1574892812666171108124218

Review Article

Research Article

Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*

View Abstract View on PubMed

Reduced Lipocalin 2 Expression Contributes to Vincristine Resistance in Human Colon Cancer Cells

Xiao Guo, Qin Li, Yan-Fang Wang, Tian-Yun Wang*, Si-Jia Chen and Zheng-Wei Tian

View Abstract View on PubMed

Advances in the Discovery of Anthraquinone-Based Anticancer Agents

Alexander Tikhomirov*, Alexander Shtil and Andrey Shchekotikhin

View Abstract View on PubMed

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

Federica Iannelli, Rita Lombardi, Maria Rita Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon and Francesca Bruzzese*

View Abstract View on PubMed

Anti-oxidants as chemopreventive agents in prostate cancer: A gap between preclinical and clinical studies

Monireh Mohsenzadegan*, Farhad Seif, Mohammad Morad Farajollahi and Majid Khoshmirsafa

View Abstract

Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents

, 2017; 12(3): 190 - 207

Stephanie Lucas, Claire Soave, Ghazal Nabil, Zainab Sabry Othman Ahmed, Guohua Chen, Hossny Awad El-Banna, Q. Ping Dou* and Jian Wang*

DOI: 10.2174/1574892812666170619125503

Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent

, 2017; 12(2): 174 - 185

Shirin Mollazadeh, Jamal Shamsara, Maryam Iman* and Farzin Hadizadeh*

DOI: 10.2174/1574892812666170126162521

Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review

, 2017; 12(1): 55 - 72

Anuj K. Rathi, Riyaz Syed, Vijay Singh, Han-Seung Shin and Rahul V. Patel

DOI: 10.2174/1574892811666161003112119

Recent Patents on Proteasome Inhibitors of Natural Origin

, 2017; 12(1): 4 - 15

Daniela Correia da Silva, Paula B. Andrade, Vera Ribeiro, Patricia Valentao and David M. Pereira

DOI: 10.2174/1574892812666161123142037

Webmaster Contact:
Copyright © 2018 Bentham Science